… ,” said Mike Mahoney, chair and CEO, Boston Scientific. “As we shared at our … and commitment to scaling capabilities.” Boston Scientific expects net sales growth for … to support growth in Minnesota. Boston Scientific sold a Minnesota facility earlier …

… EluPro™ and CanGaroo® bioenvelopes, to Boston Scientific Corporation (NYSE: BSX) for $88 … 2027,” said Dr. Randy Mills, CEO of Elutia. “We are confident …

… , as FastWave Co-Founder and CEO Scott Nelson explains. "At … engineering. With prior roles at Boston Scientific, Abbott, and St. Jude Medical …

… high-density mapping catheter,” said CEO Geoff Martha. Medtronic isn’t … : Medtronic — Cardiovascular Abbott – Cardiovascular businesses* Boston Scientific – Cardiovascular Johnson & Johnson MedTech …

… EluPro and CanGaroo bioenvelopes to Boston Scientific for $88m in cash. This … biological response to injury. Elutia CEO Dr Randy Mills said: “EluPro … in this transaction. In March, Boston Scientific announced the acquisition of SoniVie …

… receiving implantable medical devices, to Boston Scientific Corporation (NYSE: BSX) for $88 … scale,” said Dr. Randy Mills, CEO of Elutia. “With the successful …

… update Wednesday. Sharing information from Boston Scientific, the FDA said implanting the … need additional management. Dive Insight: Boston Scientific’s letter to customers covers … and Boston Scientific is now looking to increase revenue globally, as CEO Mike …

… , according to the FDA. Medtronic, Boston Scientific and Johnson & Johnson have … by competitors in PFA, Abbott CEO Robert Ford told investors in … existing PFA platforms. This summer, Boston Scientific received an expanded label to …

… previously served as President and CEO of Cyberonics, where he led … spent nearly two decades at Boston Scientific, holding several senior executive positions …

… CLTI at baseline. In 2025, Boston Scientific also shared data from its … Johnson (J&J) and Boston Scientific gained FDA clearance for their … now, the new company’s CEO, Namal Nawana, will be able …